Skip to main content
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.955
-0.085 (-1.69%)
Dec 3, 2024, 1:13 PM EST - Market open

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $47.65M in the quarter ending September 30, 2024, with 22.76% growth. This brings the company's revenue in the last twelve months to $190.86M, down -9.91% year-over-year. In the year 2023, Vanda Pharmaceuticals had annual revenue of $192.64M, down -24.27%.

Revenue (ttm)
$190.86M
Revenue Growth
-9.91%
P/S Ratio
1.53
Revenue / Employee
$940,187
Employees
203
Market Cap
288.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020248.17M20.98M9.23%
Dec 31, 2019227.19M34.07M17.64%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
Nyxoah 5.67M
Artiva Biotherapeutics 2.60M
Immutep 2.56M
Perspective Therapeutics 1.56M
Atai Life Sciences 331.00K
aTyr Pharma 235.00K
Revenue Rankings

VNDA News

More News